Subscribe To
VRTX / Vertex Pharmaceuticals (VRTX) Increases Yet Falls Behind Market: What Investors Need to Know
VRTX News
By Zacks Investment Research
November 2, 2023
Vertex Pharmaceuticals (VRTX) Rises Higher Than Market: Key Facts
The latest trading day saw Vertex Pharmaceuticals (VRTX) settling at $376.55, representing a +1.95% change from its previous close. more_horizontal
By Zacks Investment Research
October 27, 2023
Vertex Pharmaceuticals (VRTX) Declines More Than Market: Some Information for Investors
In the closing of the recent trading day, Vertex Pharmaceuticals (VRTX) stood at $355.28, denoting a -1.66% change from the preceding trading day. more_horizontal
By The Motley Fool
October 26, 2023
This Market-Beating Growth Stock Is Set to Outperform Yet Again in 2024
Large-cap growth stocks with wide economic moats and top-shelf management teams have outperformed this year. Vertex Pharmaceuticals, a rare disease sp more_horizontal
By Zacks Investment Research
October 23, 2023
Vertex Pharmaceuticals (VRTX) Increases Despite Market Slip: Here's What You Need to Know
In the closing of the recent trading day, Vertex Pharmaceuticals (VRTX) stood at $367.66, denoting a +1.6% change from the preceding trading day. more_horizontal
By Zacks Investment Research
October 17, 2023
Why Vertex (VRTX) is Poised to Beat Earnings Estimates Again
Vertex (VRTX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat i more_horizontal
By Zacks Investment Research
October 16, 2023
Vertex Pharmaceuticals (VRTX) Increases Yet Falls Behind Market: What Investors Need to Know
In the closing of the recent trading day, Vertex Pharmaceuticals (VRTX) stood at $374, denoting a +0.81% change from the preceding trading day. more_horizontal
By The Motley Fool
October 15, 2023
Is Vertex Pharmaceuticals Stock a Buy Now?
Vertex's sales have been slowing down, and this year the top line may rise by less than 10%. The company has multiple assets in phase 3 trials, which more_horizontal
By Investors Business Daily
October 12, 2023
The Surprising $5 Billion Opportunity That Drove Vertex Pharmaceuticals Stock To A Record High
Almost three-quarters of prescribed pain meds are opioids, and Vertex could change that. VRTX stock broke out to a record high Thursday. more_horizontal